A novel encapsulated nanoparticle EPR imaging agent has been described which could be used in the future to bring EPR imaging for guidance of radiotherapy into clinical reality.

The global intracardiac imaging market is expected to reach USD 1.3 billion by 2034, growing at a CAGR of 5.8%. The US market is projected to see a moderate increase at a CAGR of 2.7% due to ...

The global photoacoustic microscopy market is on a strong growth trajectory, with projections indicating a significant rise in market value. By 2024, the market is expected to reach USD 120 billion, ...

Nanozymes are synthetic materials that have enzyme-like catalytic properties, and they are broadly used for biomedical purposes, such as disease diagnostics. However, inorganic nanozymes are generally ...

Nanozymes are synthetic materials that have enzyme-like catalytic properties, and they are broadly used for biomedical ...

Nanozymes are synthetic materials that have enzyme-like catalytic properties, and they are broadly used for biomedical purposes, such as disease ...

Breathing, eating, sleeping, running to Taco Bell in the middle of the night – none of these activities would be possible ...

Scientific discoveries often come from connecting the dots between ideas that seem completely unrelated. A research team at ...

EPR Properties (NYSE: EPR) made a hard, but necessary, decision during the coronavirus pandemic's height. It suspended its dividend to ensure that it had the liquidity to survive and help its ...